NL-OMON21368招募中不适用
Risk-adapted approach for fever and neutropenia in pediatric cancer patients.
niversity Medical Center of GroningenHanzeplein 19713 GZ Groningen0 个研究点目标入组 270 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 270
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Outpatient cancer patient treated with chemotherapeutic agents;
排除标准
- •1. Non-neutropenic patients;
- •2. No informed consent;
研究者
相似试验
已完成
不适用
Study of patient risk factors for febrile neutropenia in NHL receiving (R)CHOP regimen 2on Hodgkin's LymphomaJPRN-UMIN000029534The Cancer Institute Hospital Of JFCR239
已完成
不适用
Study Of Patient risk factors for Febrile Neutropenia in NHL patients receiving (R)CHOP regimeon Hodgkin's LymphomaJPRN-UMIN000015121The Cancer Institute Hospital Of JFCR400
已完成
不适用
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After ChemotherapyAcute Myeloid Leukemia (AML)NCT04081753Augusta University12
Unknown
4 期
Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile NeutropeniaFeverFebrile NeutropeniaNCT02463747Tel-Aviv Sourasky Medical Center110
已完成
不适用
Personalised Risk assessment in Febrile illness to Optimise Real-life Management across the European Union (PERFORM) <br>febrile illness10019815NL-OMON43233Radboud Universitair Medisch Centrum1,600